Panos Andonyadis v. HHS - Influenza, Guillain-Barre syndrome (GBS) (2022)

Panos Andonyadis filed a petition on March 23, 2020, alleging that he developed Guillain-Barre syndrome (GBS) after receiving an Influenza vaccine on August 15, 2018. He claimed the GBS resulted in significant extremity weakness, partial paralysis, and visual fatigue, or alternatively, that the vaccine significantly aggravated an underlying disorder leading to GBS.

The respondent, the Secretary of Health and Human Services, denied that the vaccine caused the alleged injuries or petitioner's current condition. Despite maintaining their respective positions, the parties reached a stipulation for an award.

Special Master Thomas L. Gowen adopted the stipulation, awarding Mr.

Andonyadis $55,496.04 as compensation for all damages available under the program. The award was to be paid as a lump sum via check.

The decision was filed on April 12, 2022. Petitioner's counsel was Glen Howard Sturtevant, Jr. of Rawls Law Group, and respondent's counsel was Parisa Tabassian of the Department of Justice.

The public decision does not describe the specific onset of symptoms, medical tests, treatments, or expert witnesses. The specific mechanism of causation was not detailed in the public decision.